Kawasaki disease in an infant after administration of hexavalent vaccine

Meshal Z Almeshary1, Saud A Alanazi1, Khalid M Almoosa1

  • 1From the Department of Pediatrics, King Saud University Medical City, Riyadh, Kingdom of Saudi Arabia.

Saudi Medical Journal
|June 30, 2021
PubMed

Insights

Kawasaki disease, a rare condition in children, involves blood vessels. A case study suggests a possible, though unproven, link between hexavalent vaccines and this condition in infants.

Area of Science:

  • Pediatric Vascular Medicine
  • Immunology and Vaccine Safety

Background:

  • Kawasaki disease is a leading cause of acquired heart disease in children, characterized by inflammation of medium-sized arteries.
  • The etiology of Kawasaki disease remains unknown, prompting investigation into potential environmental triggers.
  • Concerns exist regarding a potential association between childhood vaccinations and Kawasaki disease, necessitating careful evaluation.

Observation:

  • This report details a case of incomplete Kawasaki disease in a 4-month-old infant occurring shortly after hexavalent vaccination.
  • The infant presented with significant dilatation of all coronary arteries, a major complication of Kawasaki disease.

Findings:

  • The temporal association between hexavalent vaccination and the onset of incomplete Kawasaki disease and coronary artery dilatation was noted.
  • No definitive causal link or increased risk of Kawasaki disease following vaccination has been established in current scientific literature.

Implications:

  • While this case highlights a rare possibility, current evidence does not support a causal relationship between vaccines and Kawasaki disease.
  • Further research and surveillance are warranted to thoroughly investigate potential adverse effects and understand the multifactorial etiology of Kawasaki disease.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
65
Vaccinations01:51

Vaccinations

Overview
47.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
138